Read more

January 30, 2023
1 min read
Save

Top in cardiology: Surge in CVD deaths; cardiac amyloidosis guidance

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

CVD-related deaths increased from 874,613 in 2019 to 928,741 in 2020, according to a report from the American Heart Association.

This represents the largest single-year increase since 2015, and the highest single-year occurrence of CVD deaths since 2003. It was the top story in cardiology last week.

3D Anatomical Heart_297050149
CVD-related deaths increased from 874,613 in 2019 to 928,741 in 2020, according to a report from the American Heart Association. Source: Adobe Stock

Another top story was about a decision pathway published by the American College of Cardiology that highlights the importance of recognizing and diagnosing cardiac amyloidosis at an early stage.

Read these and more top stories in cardiology below:

Total CVD deaths during early period of pandemic highest since 2003

Heart disease remained among the leading causes of death, even amid the COVID-19 pandemic, which may have exacerbated preexisting CVD morbidity-related racial/ethnic disparities, researchers reported. Read more.

ACC: Early recognition, diagnosis of cardiac amyloidosis critical

A new expert consensus decision pathway published by the American College of Cardiology highlights the importance of recognizing and diagnosing cardiac amyloidosis at an early stage to allow the most favorable outcome. Read more.

Scientific statement suggests more consideration for surgery in high-risk patients with PE

Evidence suggests that high-risk patients with pulmonary embolism can benefit from surgical management, according to a scientific statement issued by the American Heart Association. Read more.

Delays in ablation after AF diagnosis increase mortality risk

A delay in time to catheter ablation after an atrial fibrillation diagnosis is associated with increased mortality risk as well as trends of increased risk for heart failure hospitalization and atrial fibrillation recurrence, researchers reported. Read more.

Sarcopenia prevalence high with HFrEF, predicts adverse outcomes

Sarcopenia significantly increases risk for adverse outcomes in adults with heart failure with reduced ejection fraction, including death and rehospitalization, as well as risk for falls and hospitalization, researchers reported. Read more.